A molecular trap against COVID-19
- 4 September 2020
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 369 (6508) , 1167-1168
Abstract
Structure-function studies reveal a new receptor decoy to block virus entryKeywords
This publication has 11 references indexed in Scilit:
- Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2Science, 2020
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory TractCell, 2020
- SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug DiscoveriesVaccines, 2020
- Coronavirus membrane fusion mechanism offers a potential target for antiviral developmentAntiviral Research, 2020
- The potential danger of suboptimal antibody responses in COVID-19Nature Reviews Immunology, 2020
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoVNature Communications, 2020
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience, 2020
- AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challengesScience Translational Medicine, 2019
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human SubjectsClinical Pharmacokinetics, 2013
- Efficacy of Tremacamra, a Soluble Intercellular Adhesion Molecule 1, for Experimental Rhinovirus InfectionJAMA, 1999